Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-07-21 19:15:28
Reporting Period:
Accepted Time:
2020-07-21 19:15:28
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1812364 Relay Therapeutics Inc. RLAY () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190644 S Douglas Ingram C/o Relay Therapeutics, Inc.
399 Binney Street, 2Nd Floor
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-20 25,000 $20.00 25,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. On July 20, 2020, the reporting person purchased 25,000 shares of common stock, par value $0.001 per share, of the Issuer at a price of $20.00 per share pursuant to an underwritten public offering.